Mounjaro Eligibility and Prescriptions: What You Need to Know

Mounjaro (tirzepatide) is a groundbreaking medication primarily used for managing Type 2 diabetes and obesity. Recently, its applications have expanded, leading to updated guidelines and eligibility criteria in the UK.

Here's what you need to know about obtaining Mounjaro through NHS and private prescriptions:

Eligibility Criteria and BMI Requirements

Mounjaro is authorised for adult patients with a Body Mass Index (BMI) of 30kg/m² or more, qualifying them as obese. Additionally, it is available for those with a BMI between 27-30kg/m² if they have weight-related comorbidities such as cardiovascular disease. For individuals from South Asian, Chinese, other Asian, Middle Eastern, and Black ethnicities, BMI thresholds are generally lowered by 2.5 kg/m² due to differing health risk profiles.

NHS Prescription

As of October 2024, the National Institute for Health and Care Excellence (NICE) announced a forthcoming consultation to integrate Mounjaro into the NHS for weight loss treatment. Until this integration is complete, Mounjaro is not routinely available on the NHS for weight management, though it remains accessible for diabetes treatment.

Private Prescription

To obtain Mounjaro through a private prescription, one must consult a healthcare professional who is not operating under NHS jurisdiction. Private prescriptions, differing from NHS prescriptions, are not covered by NHS expenses and must be wholly paid by the patient. Here at AJ Hill Aesthetics, we’re here to help, our care for your health is paramount every step of the way with your Mounjaro prescription.

Contraindications and Side Effects

Healthcare professionals must evaluate patient history and concomitant medications before prescribing Mounjaro. Contraindications include a history of pancreatitis, severe gastrointestinal disease, and certain thyroid disorders. Awareness of these contraindications helps in averting adverse reactions which could lead to severe health complications.

Reported Side Effects 

Common side effects for GLP-1RA medications, including Mounjaro, involve gastrointestinal issues such as nausea, vomiting, diarrhoea, and constipation. While these are usually non-serious, they can progress to severe dehydration, potentially necessitating hospitalisation. Less common but serious side effects include pancreatitis, gallstone disease, and serious allergic reactions.

Monitoring and Misuse Prevention

Monitoring Protocols

 Healthcare professionals are advised to monitor patients for signs of hypoglycemia, especially non-diabetic patients using Mounjaro for weight management. Misuse of GLP-1RAs for unapproved aesthetic weight loss is a concern, and there are reports of counterfeit products containing dangerous substances like insulin.

It's crucial to counsel patients on using these medications within their licensed indications and recognising early symptoms of adverse reactions. This is one of the reasons aftercare is so important, it is a priority for us here at AJ Hill Aesthetics.

Reporting Adverse Reactions 

Professionals are encouraged to report any adverse drug reactions to the MHRA's Yellow Card scheme, which collects data to improve the safe use of medicines. Detailed reporting, including patient BMI, medical history, and source of the medication, supports the ongoing evaluation of the drug's safety profile.

Steps for Obtaining Mounjaro

Obtaining Mounjaro on the NHS

1. Consultation: Discuss eligibility and potential benefits with your GP, focusing on whether you meet the BMI and comorbidity criteria.

2. Consult NICE Guidelines: Follow updates regarding Mounjaro's phased integration into NHS services for weight loss treatment.

Obtaining Mounjaro Privately

1. Private Consultation: Schedule an appointment with a private healthcare provider to assess your eligibility.

2. Prescription: A private prescription will be provided if you meet the criteria.

Key Takeaway

In summary, obtaining Mounjaro in the UK involves careful navigation of eligibility criteria, understanding NHS and private prescription processes, and being aware of potential side effects and contraindications. The accurate use and monitoring of Mounjaro can lead to significant health benefits for those managing diabetes or obesity.